Concepedia

295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial

Axel Grothey, Kim Jordan, O Kellner, Carolina Constantin, Georg Dietrich, Hendrik Kroening, LG Mantovani, C. Schlichting, Helmut Forstbauer, Hans‐Joachim Schmoll

European Journal of Cancer Supplements · 2003 · 63 citations · 0 references

DOI

Concepts